Coexpression of α6β4 integrin and guanine nucleotide exchange factor net1 identifies node-positive breast cancer patients at high risk for distant metastasis

Michael Z. Gilcrease, Shannan K. Kilpatrick, Wendy A. Woodward, Xiao Zhou, Marlo M. Nicolas, Lynda J. Corley, Gregory N. Fuller, Susan L. Tucker, Leslie K. Diaz, Thomas A. Buchholz, Jeffrey A. Frost

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Preclinical data indicate that α6β4 integrin signaling through Ras homolog gene family, member A, plays an important role in tumor cell motility. The objective of this study was to determine whether the combined expression of α6β4 integrin and neuroepithelioma transforming gene 1 (Net1), a guanine nucleotide exchange factor specific for Ras homolog gene family member A, is associated with adverse clinical outcome in breast cancer patients. Immunohistochemical expression of each protein was evaluated in a tumor tissue microarray prepared from the primary tumors of 94 node-positive patients with invasive breast carcinoma treated with total mastectomy and doxorubicin-based chemotherapy without radiation with a median follow-up of 12.5 years. Associations between staining results and multiple clinicopathologic variables were investigated. Although there was no significant association between α6β4 integrin or Net1 expression and clinical outcome when each marker was considered individually, coexpression of α6β4 and Net1 was associated with decreased distant metastasis-free survival (P = 0.030). In the subset of patients with hormone receptor-positive tumors, coexpression of α6β4 and Net1 was associated with a decrease in distant metastasis-free and overall survival (P < 0.001 and P = 0.006, respectively). Although an association between human epidermal growth factor receptor 2 expression and coexpression of α6β4 and Net1 (P = 0.008) was observed, coexpression of α6β4 and Net1 (hazard ratio, 1.63; P = 0.02) and lymphovascular invasion (hazard ratio, 2.35; P = 0.02) were the only factors independently associated with the development of distant metastasis in multivariate analysis. These findings suggest that coexpression of α6β4 integrin and Net1 could be a useful biomarker for aggressive disease in node-positive breast cancer patients.

Original languageEnglish (US)
Pages (from-to)80-86
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume18
Issue number1
DOIs
StatePublished - Jan 2009
Externally publishedYes

Fingerprint

Guanine Nucleotide Exchange Factors
Oncogenes
Integrins
Breast Neoplasms
Neoplasm Metastasis
ras Genes
Neoplasms
Simple Mastectomy
Survival
Doxorubicin
Cell Movement
Multivariate Analysis
Biomarkers
Hormones
Radiation
Staining and Labeling
Gene Expression
Drug Therapy

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Coexpression of α6β4 integrin and guanine nucleotide exchange factor net1 identifies node-positive breast cancer patients at high risk for distant metastasis. / Gilcrease, Michael Z.; Kilpatrick, Shannan K.; Woodward, Wendy A.; Zhou, Xiao; Nicolas, Marlo M.; Corley, Lynda J.; Fuller, Gregory N.; Tucker, Susan L.; Diaz, Leslie K.; Buchholz, Thomas A.; Frost, Jeffrey A.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 18, No. 1, 01.2009, p. 80-86.

Research output: Contribution to journalArticle

Gilcrease, MZ, Kilpatrick, SK, Woodward, WA, Zhou, X, Nicolas, MM, Corley, LJ, Fuller, GN, Tucker, SL, Diaz, LK, Buchholz, TA & Frost, JA 2009, 'Coexpression of α6β4 integrin and guanine nucleotide exchange factor net1 identifies node-positive breast cancer patients at high risk for distant metastasis', Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 1, pp. 80-86. https://doi.org/10.1158/1055-9965.EPI-08-0842
Gilcrease, Michael Z. ; Kilpatrick, Shannan K. ; Woodward, Wendy A. ; Zhou, Xiao ; Nicolas, Marlo M. ; Corley, Lynda J. ; Fuller, Gregory N. ; Tucker, Susan L. ; Diaz, Leslie K. ; Buchholz, Thomas A. ; Frost, Jeffrey A. / Coexpression of α6β4 integrin and guanine nucleotide exchange factor net1 identifies node-positive breast cancer patients at high risk for distant metastasis. In: Cancer Epidemiology Biomarkers and Prevention. 2009 ; Vol. 18, No. 1. pp. 80-86.
@article{74ac9dad3ff1453aa5720e735a1a6d17,
title = "Coexpression of α6β4 integrin and guanine nucleotide exchange factor net1 identifies node-positive breast cancer patients at high risk for distant metastasis",
abstract = "Preclinical data indicate that α6β4 integrin signaling through Ras homolog gene family, member A, plays an important role in tumor cell motility. The objective of this study was to determine whether the combined expression of α6β4 integrin and neuroepithelioma transforming gene 1 (Net1), a guanine nucleotide exchange factor specific for Ras homolog gene family member A, is associated with adverse clinical outcome in breast cancer patients. Immunohistochemical expression of each protein was evaluated in a tumor tissue microarray prepared from the primary tumors of 94 node-positive patients with invasive breast carcinoma treated with total mastectomy and doxorubicin-based chemotherapy without radiation with a median follow-up of 12.5 years. Associations between staining results and multiple clinicopathologic variables were investigated. Although there was no significant association between α6β4 integrin or Net1 expression and clinical outcome when each marker was considered individually, coexpression of α6β4 and Net1 was associated with decreased distant metastasis-free survival (P = 0.030). In the subset of patients with hormone receptor-positive tumors, coexpression of α6β4 and Net1 was associated with a decrease in distant metastasis-free and overall survival (P < 0.001 and P = 0.006, respectively). Although an association between human epidermal growth factor receptor 2 expression and coexpression of α6β4 and Net1 (P = 0.008) was observed, coexpression of α6β4 and Net1 (hazard ratio, 1.63; P = 0.02) and lymphovascular invasion (hazard ratio, 2.35; P = 0.02) were the only factors independently associated with the development of distant metastasis in multivariate analysis. These findings suggest that coexpression of α6β4 integrin and Net1 could be a useful biomarker for aggressive disease in node-positive breast cancer patients.",
author = "Gilcrease, {Michael Z.} and Kilpatrick, {Shannan K.} and Woodward, {Wendy A.} and Xiao Zhou and Nicolas, {Marlo M.} and Corley, {Lynda J.} and Fuller, {Gregory N.} and Tucker, {Susan L.} and Diaz, {Leslie K.} and Buchholz, {Thomas A.} and Frost, {Jeffrey A.}",
year = "2009",
month = "1",
doi = "10.1158/1055-9965.EPI-08-0842",
language = "English (US)",
volume = "18",
pages = "80--86",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Coexpression of α6β4 integrin and guanine nucleotide exchange factor net1 identifies node-positive breast cancer patients at high risk for distant metastasis

AU - Gilcrease, Michael Z.

AU - Kilpatrick, Shannan K.

AU - Woodward, Wendy A.

AU - Zhou, Xiao

AU - Nicolas, Marlo M.

AU - Corley, Lynda J.

AU - Fuller, Gregory N.

AU - Tucker, Susan L.

AU - Diaz, Leslie K.

AU - Buchholz, Thomas A.

AU - Frost, Jeffrey A.

PY - 2009/1

Y1 - 2009/1

N2 - Preclinical data indicate that α6β4 integrin signaling through Ras homolog gene family, member A, plays an important role in tumor cell motility. The objective of this study was to determine whether the combined expression of α6β4 integrin and neuroepithelioma transforming gene 1 (Net1), a guanine nucleotide exchange factor specific for Ras homolog gene family member A, is associated with adverse clinical outcome in breast cancer patients. Immunohistochemical expression of each protein was evaluated in a tumor tissue microarray prepared from the primary tumors of 94 node-positive patients with invasive breast carcinoma treated with total mastectomy and doxorubicin-based chemotherapy without radiation with a median follow-up of 12.5 years. Associations between staining results and multiple clinicopathologic variables were investigated. Although there was no significant association between α6β4 integrin or Net1 expression and clinical outcome when each marker was considered individually, coexpression of α6β4 and Net1 was associated with decreased distant metastasis-free survival (P = 0.030). In the subset of patients with hormone receptor-positive tumors, coexpression of α6β4 and Net1 was associated with a decrease in distant metastasis-free and overall survival (P < 0.001 and P = 0.006, respectively). Although an association between human epidermal growth factor receptor 2 expression and coexpression of α6β4 and Net1 (P = 0.008) was observed, coexpression of α6β4 and Net1 (hazard ratio, 1.63; P = 0.02) and lymphovascular invasion (hazard ratio, 2.35; P = 0.02) were the only factors independently associated with the development of distant metastasis in multivariate analysis. These findings suggest that coexpression of α6β4 integrin and Net1 could be a useful biomarker for aggressive disease in node-positive breast cancer patients.

AB - Preclinical data indicate that α6β4 integrin signaling through Ras homolog gene family, member A, plays an important role in tumor cell motility. The objective of this study was to determine whether the combined expression of α6β4 integrin and neuroepithelioma transforming gene 1 (Net1), a guanine nucleotide exchange factor specific for Ras homolog gene family member A, is associated with adverse clinical outcome in breast cancer patients. Immunohistochemical expression of each protein was evaluated in a tumor tissue microarray prepared from the primary tumors of 94 node-positive patients with invasive breast carcinoma treated with total mastectomy and doxorubicin-based chemotherapy without radiation with a median follow-up of 12.5 years. Associations between staining results and multiple clinicopathologic variables were investigated. Although there was no significant association between α6β4 integrin or Net1 expression and clinical outcome when each marker was considered individually, coexpression of α6β4 and Net1 was associated with decreased distant metastasis-free survival (P = 0.030). In the subset of patients with hormone receptor-positive tumors, coexpression of α6β4 and Net1 was associated with a decrease in distant metastasis-free and overall survival (P < 0.001 and P = 0.006, respectively). Although an association between human epidermal growth factor receptor 2 expression and coexpression of α6β4 and Net1 (P = 0.008) was observed, coexpression of α6β4 and Net1 (hazard ratio, 1.63; P = 0.02) and lymphovascular invasion (hazard ratio, 2.35; P = 0.02) were the only factors independently associated with the development of distant metastasis in multivariate analysis. These findings suggest that coexpression of α6β4 integrin and Net1 could be a useful biomarker for aggressive disease in node-positive breast cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=58349121443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58349121443&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-08-0842

DO - 10.1158/1055-9965.EPI-08-0842

M3 - Article

C2 - 19124484

AN - SCOPUS:58349121443

VL - 18

SP - 80

EP - 86

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -